JOHN HAMMOND: Open Payments
NPI 1154766905 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 52 payments from 14 companies in 2025. Trend: 2023 $748 · 2024 $920 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $240 |
| Vanda Pharmaceuticals Inc. | 5 | $144 |
| Tris Pharma Inc | 5 | $117 |
| Otsuka America Pharmaceutical, Inc. | 4 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Alpha Cognition USA, Inc. | 1 | $92 |
| Alkermes, Inc. | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $55 |
| Corium, LLC | 2 | $51 |
Products named: REXULTI, FANAPT, Dyanavel XR, CAPLYTA, Zunveyl, ARISTADA, AUSTEDO XR, VRAYLAR.
Industry payments across AL — which companies pay providers there.
